NOX
ASX:NOX
Noxopharm Limited
- Stock
Last Close
0.09
30/08 06:10
Market Cap
19.29M
Beta: 1.40
Volume Today
175.85K
Avg: 459.45K
PE Ratio
−1.07
PFCF: −1.47
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 35.25K - | 95.94K 172.17% | 320.31K 233.85% | 415.37K 29.68% | 729.00K 75.51% | 573.25K 21.37% | |||
average payables | 271.52K - | 588.80K 116.86% | 1.19M 101.61% | 1.64M 37.90% | 3.96M 141.82% | 3.47M 12.33% | 629.21K 81.87% | ||
average receivables | 34.18K - | 92.61K 170.96% | 141.52K 52.81% | 2.40M 1,598.35% | 5.22M 117.30% | 5.51M 5.43% | 5.65M 2.59% | ||
book value per share | 0.18 - | 0.03 84.10% | 0.09 202.56% | -0.00 100.85% | 0.09 12,867.58% | 0.15 66.10% | 0.08 46.41% | ||
capex per share | -0.00 - | -0.00 191.60% | -0.00 98.24% | -0.00 53.17% | |||||
capex to depreciation | -2.60 - | -5.30 103.66% | |||||||
capex to operating cash flow | 0.03 - | ||||||||
capex to revenue | |||||||||
cash per share | 0.18 - | 0.03 84.75% | 0.11 277.55% | 0.02 80.13% | 0.05 143.67% | 0.10 97.90% | 0.05 52.63% | ||
days of inventory on hand | |||||||||
days payables outstanding | |||||||||
days sales outstanding | |||||||||
debt to assets | 0.23 - | 0.91 305.47% | 0.25 72.74% | 0.01 97.07% | 0.01 17.26% | ||||
debt to equity | 0.32 - | -39.04 12,180.57% | 0.39 100.99% | 0.01 97.79% | 0.01 22.26% | ||||
dividend yield | 0.42 - | ||||||||
earnings yield | -0.10 - | -0.25 164.24% | -0.18 29.87% | -0.99 459.62% | -0.14 85.46% | -0.33 129.77% | |||
enterprise value | 30.98K - | 29.51M 95,150.43% | 63.28M 114.45% | 64.57M 2.05% | 20.73M 67.90% | 143.74M 593.41% | 42.94M 70.13% | -3.01M 107.01% | |
enterprise value over ebitda | -9.19 - | -3.51 61.81% | -5.44 55.08% | 7.65 240.55% | -20.84 372.26% | -2.34 88.76% | |||
ev to operating cash flow | -10.11 - | -16.24 - | -2.32 85.70% | 0.27 111.83% | |||||
ev to sales | |||||||||
free cash flow per share | -0.03 - | -0.00 92.33% | -0.00 98.24% | -0.00 53.17% | -0.03 154,599.58% | -0.06 89.21% | |||
free cash flow yield | -0.09 - | -0.00 95.41% | -0.00 97.66% | -0.00 30.55% | -0.05 39,474.31% | -0.33 525.83% | |||
graham net net | 0.18 - | 0.02 86.12% | 0.07 186.19% | -0.02 127.49% | 0.03 237.01% | 0.09 247.97% | 0.06 40.09% | ||
graham number | 0.15 - | 0.54 265.53% | 0.04 93.28% | 0.58 1,500.90% | 0.57 2.85% | 0.35 38.99% | |||
income quality | 0.96 - | 0.99 - | |||||||
intangibles to total assets | 0 - | 0.00 Infinity% | 0.00 836.62% | 0.01 238.32% | 0 100% | 0 | 0 | 0 | |
interest coverage | -75.88 - | -18.32 75.86% | 0.71 103.89% | -3.28 560.22% | -240.38 7,239.05% | ||||
interest debt per share | 0.03 - | 0.03 12.21% | 0.06 84.54% | 0.01 84.30% | 0.00 91.50% | ||||
inventory turnover | |||||||||
invested capital | 0.32 - | -39.04 12,180.57% | 0.39 100.99% | 0.01 97.79% | 0.01 22.26% | ||||
market cap | 6.21M - | 31.96M 414.83% | 72.61M 127.16% | 63.55M 12.48% | 22.83M 64.08% | 170.18M 645.47% | 56.79M 66.63% | ||
net current asset value | 5.93M - | 2.21M 62.79% | 9.67M 338.50% | -1.86M 119.26% | 5.13M 375.61% | 25.90M 404.32% | 18.36M 29.11% | 8.10M 55.86% | |
net debt to ebitda | 0.77 - | 0.52 32.37% | -0.09 116.62% | -0.78 800.76% | 3.83 594.45% | 0.76 80.29% | |||
net income per share | -0.03 - | -0.15 341.61% | -0.08 47.11% | -0.16 100.73% | -0.09 43.18% | -0.06 30.53% | |||
operating cash flow per share | -0.03 - | -0.03 - | -0.06 89.21% | ||||||
payables turnover | |||||||||
receivables turnover | |||||||||
research and ddevelopement to revenue | |||||||||
return on tangible assets | -1.08 - | -1.26 16.96% | -2.63 108.94% | -1.12 57.29% | -0.51 54.56% | -0.70 37.97% | |||
revenue per share | |||||||||
roe | -1.23 - | -1.80 45.96% | 111.48 6,287.27% | -1.75 101.57% | -0.60 65.79% | -0.78 29.63% | |||
roic | -1.23 - | -1.34 9.32% | -2.78 106.76% | 3.01 208.15% | -0.45 115.03% | -0.76 69.14% | |||
sales general and administrative to revenue | |||||||||
shareholders equity per share | 0.18 - | 0.03 84.10% | 0.09 202.56% | -0.00 100.85% | 0.09 12,867.58% | 0.15 66.10% | 0.08 46.41% | ||
stock based compensation to revenue | |||||||||
tangible asset value | 5.95M - | 2.47M 58.51% | 10.11M 309.89% | -1.49M 114.71% | 12.87M 965.41% | 40.78M 216.76% | 24.12M 40.85% | 9.07M 62.38% | |
tangible book value per share | 0.18 - | 0.03 84.10% | 0.08 201.55% | -0.01 112.68% | 0.09 964.14% | 0.15 66.10% | 0.08 46.41% | ||
working capital | 5.93M - | 2.21M 62.79% | 12.95M 487.14% | -1.86M 114.38% | 5.64M 402.92% | 26.17M 363.64% | 18.55M 29.10% | 8.20M 55.82% |
All numbers in AUD (except ratios and percentages)